{"url_path":"/sec/nwbo/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1072379/0001104659-26-062661-index.html","accession_number":"0001104659-26-062661","cik":"0001072379","ticker":"NWBO","issuer_name":"NORTHWEST BIOTHERAPEUTICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1072379/0001104659-26-062661-index.html","primary_entity_key":"0001072379","primary_entity_name":"NORTHWEST BIOTHERAPEUTICS INC"},"word_count":268,"has_tables":true,"body_markdown":"Item 6. Exhibits\n\n​\n\n21.1\n\n  ​ ​ ​\n\n[Subsidiaries of the Registrant](https://www.sec.gov/Archives/edgar/data/1072379/000141057823001633/nwbo-20230630xex21d1.htm)\n\n​\n\n​\n\n​\n\n21.2\n\n​\n\n[Certificate of Incorporation on Change of Name](https://www.sec.gov/Archives/edgar/data/1072379/000141057823001633/nwbo-20230630xex21d2.htm)\n\n​\n\n​\n\n​\n\n31.1\n\n[Certification of President (Principal Executive Officer and Principal Financial and Accounting Officer), Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](nwbo-20260331xex31d1.htm)\n\n​\n\n​\n\n​\n\n32.1\n\n​\n\n[Certification of President, Chief Executive Officer and Principal Financial and Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](nwbo-20260331xex32d1.htm)\n\n​\n\n​\n\n​\n\n101.INS\n\n​\n\nInline XBRL Instance Document.\n\n​\n\n \n\n101.SCH\n\n​\n\nInline XBRL Schema Document.\n\n​\n\n \n\n101.CAL\n\n​\n\nInline XBRL Calculation Linkbase Document.\n\n​\n\n \n\n101.DEF\n\n​\n\nInline XBRL Definition Linkbase Document.\n\n​\n\n \n\n101.LAB\n\n​\n\nInline XBRL Label Linkbase Document.\n\n​\n\n \n\n101.PRE\n\n​\n\nInline XBRL Presentation Linkbase Document.\n\n​\n\n​\n\n​\n\n104\n\n​\n\nThe cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, formatted in Inline XBRL (included as Exhibit 101).\n\n*    Filed herewith\n\n**  Furnished herewith\n\n​\n\n29\n\n[Table of Contents](#TOC)\n\nSIGNATURES\n\n​\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n​\n\n​\n\nNORTHWEST BIOTHERAPEUTICS, INC\n\n​\n\n​\n\n​\n\nDated: May 15, 2026\n\nBy:\n\n/s/ Linda F. Powers\n\n​\n\n​\n\nName:\n\nLinda F. Powers\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\nTitle:\n\nPresident and Chief Executive Officer\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\nPrincipal Executive Officer\n\n​\n\n​\n\n​\n\nPrincipal Financial and Accounting Officer\n\n​\n\n​\n\n​\n\n30"}